TABLE 2.
Characteristic | Value for: |
||
---|---|---|---|
Entire study population (n = 13) | Study population by treatment group |
||
Vaccine (n = 8) | Placebo/adjuvant (n = 5) | ||
Age (median, yr) | 48 | 49 | 41 |
Gender (% male) | 69 | 50 | 100 |
Median duration of ARTa (yr) | 11 | 11 | 11 |
Median baseline CD4 cell counts (/mm3) | 760 | 768 | 731 |
Before study entry.